Niklas Grassl

8PUBLICATIONS
51CO-AUTHORS
Tumour immunologyGene expression (incl. microarray and other genome-wide approaches)Gene and molecular therapyPredictive and prognostic markersOptical technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 02, 2024
H3K27M neoepitope vaccination in diffuse midline glioma induces B and T cell responses across diverse HLA loci of a recovered patient.

Tamara Boschert, Kristina Kromer, Taga Lerner

|Jan 31, 2024
Cerebrospinal Fluid cfDNA Sequencing for Classification of Central Nervous System Glioma.

Florian Iser, Felix Hinz, Dirk C Hoffmann

|Oct 18, 2023
INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas.

Niklas Grassl, Katharina Sahm, Heike Süße

|Sep 22, 2023
A H3K27M-targeted vaccine in adults with diffuse midline glioma.

Niklas Grassl, Isabel Poschke, Katharina Lindner

|Aug 02, 2022
Pearls & Oy-sters: Hemiballism and Orbitofrontal-like Syndrome in a Patient With Unilateral Tuberothalamic Stroke.

Niklas Grassl, Anne D Ebert, Kristina Szabo

|Jul 10, 2020
Nivolumab for treatment of progressive multifocal leukoencephalopathy in Sézary syndrome.

N Grassl, L Bunse, T Beutel

Pageof 2

Frequent Collaborators

5 joint publications

Michael Platten

3 joint publications

Lukas Bunse

3 joint publications

Katharina Sahm

2 joint publications

Juliane Nees